Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ROCHE HOLDING LTD.
07/22 ROCHE : exits epigenetic drug deal
07/22 ORYZON GENOMICS : Roche Abandons Spanish Cancer Epigenetics Drug
07/22 ROCHE : s new breast cancer drug that could cut treatment time denied patent
07/22 ROCHE : Deaths
07/22 ROCHE HOLDING LTD. : DEADLINE APPROACHING: Khang & Khang LLP Announces Securitie..
07/21 ROCHE HOLDING LTD. : RHHBY The Law Offices of Vincent Wong Reminds Investors of ..
07/21 ROCHE : CHMP recommends EU approval for Roche's TECENTRIQ (atezolizumab) in a sp..
07/21 ROCHE : Combine Solicitation - Roche/Kappa Illumina LightCycler 480 qPCR MasterM..
07/21 ROCHE : gains positive CHMP opinion for Actemra / RoActemra in giant cell arteri..
07/21 ROCHE : CHMP recommends EU approval of Roche’s Gazyvaro for people with pr..
07/21 ROCHE : CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) i..
07/21 ORYZON GENOMICS : Roche punts a PhI cancer drug out of the pipeline and back to ..
07/20 ROCHE HOLDING LTD. : DEADLINE ALERT: Lundin Law PC Announces Securities Class Ac..
07/20 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/20 HALOZYME THERAPEUTICS : Initiation Of Clinical Trial Collaboration Evaluating Ha..
07/20 ROCHE HOLDING LTD. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Cla..
07/20 HALOZYME THERAPEUTICS : Genentech collaborate on pancreatic cancer trial
07/20 EXELIXIS, INC. (NASDAQ : EXEL) Files An 8-K Entry into a Material Definitive Agr..
07/20 ROCHE : Combine Solicitation - Roche Reagents
07/20 ROCHE HOLDING LTD. : SHAREHOLDER REMINDER: Khang & Khang LLP Announces Securitie..
07/19 ROCHE : Restructuring and extension of the Andr stadium Roche 12, rue Larmeroux ..
07/19 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/18 ROCHE HOLDING LTD. : DEADLINE APPROACHING: Lundin Law PC Announces Securities Cl..
07/18 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/18 ROCHE HOLDING LTD. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remi..
07/18 ROCHE : NHS supremo hails Alexion and Roche deals, but defends budget controls
07/18 ROCHE : CONTRACT AWARD - Real Time PCR System
07/18 ROCHE : $37,400 Federal Contract Awarded to Roche Diagnostics
07/17 ROCHE HOLDING LTD. : UPCOMING DEADLINE: Khang & Khang LLP Announces Securities C..
07/17 ROCHE : OCREVUS (ocrelizumab) approved for relapsing and primary progressive mul..
07/17 ROCHE : OCREVUS (ocrelizumab) approved for relapsing and primary progressive mul..
07/15 ROCHE HOLDING LTD. : UPCOMING DEADLINE: Lundin Law PC Announces Securities Class..
07/14 HALOZYME THERAPEUTICS : HALO) Announces Initiation Of Clinical Trial Collaborati..
07/14 ROCHE : Halozyme up 1% premarket on start of Roche study of PEGPH20/Tecentriq co..
07/13 ROCHE HOLDING LTD. : APPROACHING DEADLINE: Khang & Khang LLP Announces Securitie..
07/13 PTC THERAPEUTICS : Preliminary Phase 2 Data from Spinal Muscular Atrophy Program..
07/13 ROCHE HOLDING LTD. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remi..
07/13 ROCHE : Mylan/Biocon Herceptin biosimilar faces EU delay
07/13 ROCHE : With respect ...
07/12 ROCHE HOLDING LTD. : APPROACHING DEADLINE: Lundin Law PC Announces Securities Cl..
07/12 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/12 ROCHE : KIT, solution and material, compatible with use in blood and PH hemogaso..
07/11 ROCHE : Construction work for swimming pool
07/11 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
07/11 ROCHE HOLDING LTD. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Remi..
07/11 ROCHE : Positive Phase III Results for Roche's Emicizumab in Haemophilia a Publi..
07/11 ROCHE : BioLineRx Announces Initiation of Phase 1b/2 Trial of BL-8040 in Pancrea..
07/10 ROCHE HOLDING LTD. : RHHBY The Law Offices of Vincent Wong Reminds Investors of ..
07/10 ROCHE : Shire, Roche slug it out in billion-dollar haemophilia drug battle
07/10 ROCHE : Positive phase III results for Roche’s emicizumab in haemophilia A..
07/10 ROCHE : Positive Phase III Results for Genentech’s Emicizumab in Hemophili..
07/09 Shire gets injunction against Roche over hemophilia drug
07/08 ROCHE HOLDING LTD. : Lundin Law PC Announces Securities Class Action Lawsuit aga..
07/07 ROCHE : Invitation to Roche Analyst Event at ISTH 2017
07/07 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/06 ROCHE : Global Capecitabine Sales Market 2017 - ScinoPharm, Tecoland, Roche, Aar..
07/06 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
07/06 CHUGAI PHARMACEUTICAL : Bispecific Antibody Emicizumab to Present Results of Two..
07/06 ROCHE HOLDING LTD. : The Klein Law Firm Reminds Investors of a Class Action File..
07/06 ROCHE HOLDING LTD. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Cla..
07/06 ROCHE : Shanghai Runda Takes Stake in Changchun Peer, Shanghai Firm
07/05 ROCHE HOLDING LTD. : Lundin Law PC Announces Securities Class Action Lawsuit aga..
07/05 ROCHE HOLDING LTD. : URGENT: Monteverde & Associates PC Reminds Roche Holding AG..
07/05 ABNOVA TAIWAN : Fusion Protein Market 2017 - Roche, Abnova, NOVUS, Origene, ProS..
07/05 ROCHE : Synergy of medicine, genetics, computers is key in anti-cancer fight
07/05 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/05 ROCHE : Koreas anticancer drug wins FDA approval
07/04 ROCHE : Invitation to Roche Analyst Event on Diagnostics Division at AACC 2017
07/04 ROCHE : Building construction work
07/04 ROCHE : Hammond Park wins in second week of Central Maryland Swim League
07/03 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
07/03 Global in Vitro Diagnostics Devices Market 2017- Roche, Siemens, Abbott, Beck..
07/03 ROCHE : Nationwide Medical Insurance launches micro-health insurance product
07/03 ROCHE : expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to ..
07/03 ROCHE : Sources Sought - Roche/Kappa Illumina LightCycler 480 qPCR MasterMix
1  2  3  4  5  6  7  8  9  10Next
Financials ( CHF)
Sales 2017 53 064 M
EBIT 2017 18 297 M
Net income 2017 11 382 M
Debt 2017 9 072 M
Yield 2017 3,51%
P/E ratio 2017 17,86
P/E ratio 2018 16,62
EV / Sales 2017 4,12x
EV / Sales 2018 3,87x
Capitalization 209 568 M
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | RHO5 | CH0012032048 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 282  CHF
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.2.20%221 492
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.4.90%221 492
NOVARTIS8.37%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303